Hepatic histology in obese patients undergoing bariatric surgery

Journal of Hepatology

Volumn 45, Issue 4, 2006, Pages 600-606

  Machado, Mariana ^a   Marques Vidal, Pedro ^a   Cortez Pinto, Helena ^a  

^a INSTITUTO DE MEDICINA MOLECULAR JOÃO LOBO ANTUNES   (Portugal)

Author keywords

Bariatric surgery; Morbid obesity; Non alcoholic fatty liver disease; Non alcoholic steatohepatitis

Indexed keywords

ADULT; ARTICLE; BARIATRIC SURGERY; BODY MASS; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE SEVERITY; FATTY LIVER; FEMALE; HUMAN; HUMAN TISSUE; HYPERTENSION; INSULIN RESISTANCE; LIVER DISEASE; LIVER FIBROSIS; LIVER HISTOLOGY; MAJOR CLINICAL STUDY; MALE; MORBID OBESITY; NONALCOHOLIC FATTY LIVER; OBSERVATIONAL STUDY; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; SEX DIFFERENCE;

ADULT; AGE DISTRIBUTION; BARIATRIC SURGERY; BODY MASS INDEX; DYSLIPIDEMIAS; FATTY LIVER; FEMALE; HUMANS; HYPERTENSION; LIVER; LIVER CIRRHOSIS; MALE; MIDDLE AGED; OBESITY, MORBID; PREVALENCE; SEVERITY OF ILLNESS INDEX; SEX DISTRIBUTION; TRANSAMINASES;

EID: 33748110788     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2006.06.013     Document Type: Article

References (37)

1. Bedogni G., Miglioli L., Masutti F., Tiribelli C., Marchesini G., and Bellentani S. Prevalence of and risk factors for nonalcoholic fatty liver disease: the Dionysos nutrition and liver study. Hepatology 42 (2005) 44-52
2. Wanless I.R., and Lentz J.S. Fatty liver hepatitis (steatohepatitis) and obesity: an autopsy study with analysis of risk factors. Hepatology 12 (1990) 1106-1110
3. Neuschwander-Tetri B.A., and Roll F.J. Chemotatic activity for human PMN generated during ethanol metabolism by rat hepatocytes: role of glutathione and glutathione peroxidase. Biophys Res Commun 167 (1990) 1170-1176
4. Braillon A., Capron J.P., Herve M.A., Degott C., and Quenum C. Liver in obesity. Gut 26 (1985) 133-139
5. Ratziu V., Giral P., and Charlotte F. Liver fibrosis in overweight patients. Gastroenterology 118 (2000) 1117-1123
6. Marchesini G., Brizi M., Bianchi G., Tomassetti S., Bugianesi E., Lenzi M., et al. Nonalcoholic fatty liver disease: a feature of the metabolic syndrome. Diabetes 50 (2001) 1844-1850
7. Chitturi S., Abeygunasekera S., Farrell G.C., Holmes-Walker J., Hui J.M., Fung C., et al. NASH and insulin resistance: insulin hypersecretion and specific association with the insulin resistance syndrome. Hepatology 35 (2002) 373-379
8. Pagano G., Pacini G., Musso G., Gambino R., Mecca F., Depetris N., et al. Nonalcoholic steatohepatitis, insulin resistence and metabolic syndrome: further evidence for an etiologic association. Hepatology 35 (2002) 367-372
9. Flegal K.M. Trends in body weight and overweight in the U.S. population. Nutr Rev 54 (1996) S97-S100
10. Luyckx F.H., Desaive C., Thiry A., Dewe W., Scheen A.J., Gielen J.E., et al. Liver abnormalities in severely obese subjects: effect of drastic weight loss after gastroplasty. Int J Obes Relat Metab Disord 22 (1998) 222-226
11. Marceau P., Biron S., Hould F.S., Marceau S., Simard S., Thung S.N., et al. Liver pathology and the metabolic syndrome X in severe obesity. J Clin Endocrinol Metab 84 (1999) 1513-1517
12. Dixon J.B., Bhathal P.S., and O'Brien P.E. Nonalcoholic fatty liver disease: predictors of nonalcoholic steatohepatitis and liver fibrosis in the severely obese. Gastroenterology 121 (2001) 91-100
13. Sepulveda-Flores R.N., Vera-Cabrera L., Flores-Gutierrez J.P., Maldonado-Garza H., Salinas-Garza R., Zorrilla-Blanco P., et al. Obesity-related non-alcoholic steatohepatitis and TGF-beta1 serum levels in relation to morbid obesity. Ann Hepatol 1 (2002) 36-39
14. Poniachik J., Mancilla C., Contreras J., Csendes A., Smok G., Cavada G., et al. [Obesity: risk factor for steatohepatitis and hepatic fibrosis]. Rev Med Chil 130 (2002) 731-736
15. Beymer C., Kowdley K.V., Larson A., Edmonson P., Dellinger E.P., and Flum D.R. Prevalence and predictors of asymptomatic liver disease in patients undergoing gastric bypass surgery. Arch Surg 138 (2003) 1240-1244
16. Spaulding L., Trainer T., and Janiec D. Prevalence of non-alcoholic steatohepatitis in morbidly obese subjects undergoing gastric bypass. Obes Surg 13 (2003) 347-349
17. Frantzides C.T., Carlson M.A., Moore R.E., Zografakis J.G., Madan A.K., Puumala S., et al. Effect of body mass index on nonalcoholic fatty liver disease in patients undergoing minimally invasive bariatric surgery. J Gastrointest Surg 8 (2004) 849-855
18. Abrams G.A., Kunde S.S., Lazenby A.J., and Clements R.H. Portal fibrosis and hepatic steatosis in morbidly obese subjects: a spectrum of nonalcoholic fatty liver disease. Hepatology 40 (2004) 475-483
19. Shalhub S., Parsee A., Gallagher S.F., Haines K.L., Willkomm C., Brantley S.G., et al. The importance of routine liver biopsy in diagnosing nonalcoholic steatohepatitis in bariatric patients. Obes Surg 14 (2004) 54-59
20. Papadia F.S., Marinari G.M., Camerini G., Murelli F., Carlini F., Stabilini C., et al. Liver damage in severely obese patients: a clinical-biochemical-morphologic study on 1000 liver biopsies. Obes Surg 14 (2004) 952-958
21. Chavarria-Arciniega S., Lopez-Alvarenga J.C., Uribe-Uribe N.O., Herrera-Hernandez M., and Gonzalez-Barranco J. [Relationship between morphological diagnosis of NASH (non-alcoholic steatohepatitis) and liver function test in a group of patients with morbid obesity. cases study]. Rev Invest Clin 57 (2005) 505-512
22. Ong J.P., Elariny H., Collantes R., Younoszai A., Chandhoke V., Reines H.D., et al. Predictors of nonalcoholic steatohepatitis and advanced fibrosis in morbidly obese patients. Obes Surg 15 (2005) 310-315
23. Boza C., Riquelme A., Ibanez L., Duarte I., Norero E., Viviani P., et al. Predictors of nonalcoholic steatohepatitis (NASH) in obese patients undergoing gastric bypass. Obes Surg 15 (2005) 1148-1153
24. Lima M.L., Mourao S.C., Diniz M.T., and Leite V.H. Hepatic histopathology of patients with morbid obesity submitted to gastric bypass. Obes Surg 15 (2005) 661-669
25. Stratopoulos C., Papakonstantinou A., Terzis I., Spiliadi C., Dimitriades G., Komesidou V., et al. Changes in liver histology accompanying massive weight loss after gastroplasty for morbid obesity. Obes Surg 15 (2005) 1154-1160
26. Crespo J., Fernandez-Gil P., Hernandez-Guerra M., Cayon A., Mayorga M., Dominguez-Diez A., et al. Are there predictive factors of severe liver fibrosis in morbidly obese patients with non-alcoholic steatohepatitis?. Obes Surg 11 (2001) 254-257
27. Brunt E.M., Janney C.G., Di Bisceglie A.M., Neuschwander-Tetri B.A., and Bacon B.R. Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions. Am J Gastroenterol 94 (1999) 2467-2474
28. Lee R.G. Nonalcoholic steatohepatitis: tightening the morphological screws on a hepatic rambler. Hepatology 21 (1995) 1742-1744
29. Brunt E.M. Pathology of nonalcoholic steatohepatitis. Hepatol Res (2005)
30. Kleiner D.E., Brunt E.M., Van Natta M., Behling C., Contos M.J., Cummings O.W., et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 41 (2005) 1313-1321
31. Ratziu V., Charlotte F., Heurtier A., Gombert S., Giral P., Bruckert E., et al. Sampling variability of liver biopsy in nonalcoholic fatty liver disease. Gastroenterology 128 (2005) 1898-1906
32. Sherlock S., and Dooley J.C. Nutritional and metabolic liver disease. In: Sherlock S. (Ed). Diseases of the liver and biliary system. 9th edition 408 (1993), Blackwell Scientific, Oxford
33. Szczepaniak L.S., Nurenberg P., Leonard D., Browning J.D., Reingold J.S., Grundy S., et al. Magnetic resonance spectroscopy to measure hepatic triglyceride content: prevalence of hepatic steatosis in the general population. Am J Physiol Endocrinol Metab 288 (2005) E462-E468
34. Bataller R., and Brenner D.A. Liver fibrosis. J Clin Invest 115 (2005) 209-218
35. Yokohama S., Yoneda M., Haneda M., Okamoto S., Okada M., Aso K., et al. Therapeutic efficacy of an angiotensin II receptor antagonist in patients with nonalcoholic steatohepatitis. Hepatology 40 (2004) 1222-1225
36. Yokohama S., Tokusashi Y., Nakamura K., Tamaki Y., Okamoto S., Okada M., et al. Inhibitory effect of angiotensin II receptor antagonist on hepatic stellate cell activation in non-alcoholic steatohepatitis. World J Gastroenterol 12 (2006) 322-326
37. Mofrad P., Contos M.J., Haque M., Sargeant C., Fisher R.A., Luketic V.A., et al. Clinical and histologic spectrum of nonalcoholic fatty liver disease associated with normal ALT values. Hepatology 37 (2003) 1286-1292